The Virtual Biotech: A multi-agent AI framework for therapeutic discovery and development

September 17, 2026| Source: Science

Drug development requires evidence integration across biological scales and modalities, but relevant tools are fragmented. We introduce the Virtual Biotech, an organization of artificial intelligence (AI) agents modeled on a drug-development company, with agentic divisions spanning target discovery, safety assessment, modality selection, and clinical development. We demonstrate its utility at three drug-development decision points. First, over 37,000 agents annotated outcomes from 55,984 trials and found that drugs targeting cell-type-specific genes were 48% more likely to reach market with 32% fewer adverse events. Second, it integrated multimodal evidence to propose a therapeutic strategy in lung cancer. Third, it analyzed a terminated ulcerative colitis trial and inferred potential mechanisms of failure. These results demonstrate that human-guided multi-agent systems can conduct transparent, multiscale analyses to inform therapeutic-development decisions.

Read the original source →

Integrating cooperative breeding with reciprocity and culture extends Hamilton's rule to humans.

We study how kinship and reciprocity shape giving and child care support in societies with limited access to markets. Extending Hamilton's rule to incorporate reciprocity, we test it using behavioral data from dictator games and surveys in remote matrilocal and patrilocal villages of northeast India (N = 406 parents of young children). We replicate with data from urban Manila neighborhoods (N = 301) and the Solomon Islands (N = 624). Consistent with predictions, transfers to recipients increase

Artificial IntelligenceOctober 15, 2026

Multi-omics atlas of chronic exercise.

Exercise reduces all-cause mortality, yet its molecular effects across organs, sexes, and circadian phases remain incompletely understood. We subjected mice to 8 weeks of voluntary wheel running and collected 22 tissues and plasma during active and inactive phases for bulk RNA sequencing, metabolomics, proteomics, and single-nucleus RNA and methylation sequencing. Exercise induced canonical fiber-type switching and widespread, tissue-specific remodeling, with the largest transcriptomic changes i

Artificial IntelligenceOctober 14, 2026

A microexon regulatory code reveals autism-linked genetic variation.

Neuronal microexons are a highly conserved class of alternative splicing events enriched in genes with critical functions in nervous system biology 1,2 . Microexon splicing is often disrupted in the brains of autistic individuals, and mice with microexon deficiencies display autism-like phenotypes 1,3,4 . However, the full landscape of microexons is not known, and the impact of genetic variation on these exons has not been systematically investigated. Here, through extensive transcriptome profil

Artificial IntelligenceOctober 13, 2026

Deep learning of fossil pollen morphology reveals 25,000 y of ecological change in eastern African grasslands.

Grass (Poaceae) pollen is largely overlooked in investigations of grassland evolution because the pollen of most species cannot be differentiated using traditional optical microscopy. However, the combination of superresolution microscopy and deep learning enables the capture and quantification of distinct morphological variation across the pollen of grass species. Using a semisupervised deep-learning strategy, we trained convolutional neural networks (CNNs) on superresolution images of known mo

Artificial IntelligenceOctober 13, 2026

Tyrosine phosphorylation unfolds nucleophosmin and disrupts its integration into the nucleolus.

Nucleophosmin (NPM1) is a multifunctional nucleolar protein essential for ribosome biogenesis, genome stability, and stress responses. Its integration into the nucleolus depends on its oligomerization and multivalent interactions that enable liquid-liquid phase separation (LLPS). Here, we investigate how tyrosine phosphorylation at Tyr17, Tyr29, and Tyr67 located within the interface between monomers at the N-terminal oligomerization domain regulates NPM1 structure and function. Replacing tyrosi